These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 20146665)

  • 1. Identification of new pancreatic beta cell targets for in vivo imaging by a systems biology approach.
    Bouckenooghe T; Flamez D; Ortis F; Goldman S; Eizirik DL
    Curr Pharm Des; 2010 May; 16(14):1609-18. PubMed ID: 20146665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of radiotracers for the determination of the beta-cell mass in vivo.
    Brom M; Andrałojć K; Oyen WJ; Boerman OC; Gotthardt M
    Curr Pharm Des; 2010 May; 16(14):1561-7. PubMed ID: 20146667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta Cell Imaging-From Pre-Clinical Validation to First in Man Testing.
    Demine S; Schulte ML; Territo PR; Eizirik DL
    Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33019671
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo beta-cell imaging with VMAT 2 ligands--current state-of-the-art and future perspective.
    Veluthakal R; Harris P
    Curr Pharm Des; 2010 May; 16(14):1568-81. PubMed ID: 20146666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of
    Kimura H; Ogawa Y; Fujimoto H; Mukai E; Kawashima H; Arimitsu K; Toyoda K; Fujita N; Yagi Y; Hamamatsu K; Murakami T; Murakami A; Ono M; Nakamoto Y; Togashi K; Inagaki N; Saji H
    Bioorg Med Chem; 2018 Jan; 26(2):463-469. PubMed ID: 29273416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GPR44 as a Target for Imaging Pancreatic Beta-Cell Mass.
    Eriksson O
    Curr Diab Rep; 2019 Jun; 19(8):49. PubMed ID: 31250117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased VMAT2 in the pancreas of humans with type 2 diabetes mellitus measured in vivo by PET imaging.
    Cline GW; Naganawa M; Chen L; Chidsey K; Carvajal-Gonzalez S; Pawlak S; Rossulek M; Zhang Y; Bini J; McCarthy TJ; Carson RE; Calle RA
    Diabetologia; 2018 Dec; 61(12):2598-2607. PubMed ID: 29721633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systematic screening of imaging biomarkers for the Islets of Langerhans, among clinically available positron emission tomography tracers.
    Karlsson F; Antonodimitrakis PC; Eriksson O
    Nucl Med Biol; 2015 Oct; 42(10):762-9. PubMed ID: 26138288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the use of [18F]DOPA as an imaging biomarker for transplanted islet mass.
    Eriksson O; Mintz A; Liu C; Yu M; Naji A; Alavi A
    Ann Nucl Med; 2014 Jan; 28(1):47-52. PubMed ID: 24166476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-invasive detection of transplanted pancreatic islets.
    Medarova Z; Moore A
    Diabetes Obes Metab; 2008 Nov; 10 Suppl 4(0 4):88-97. PubMed ID: 18834436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-invasive imaging of beta cell mass: a quantitative analysis.
    Sweet IR; Cook DL; Lernmark A; Greenbaum CJ; Krohn KA
    Diabetes Technol Ther; 2004 Oct; 6(5):652-9. PubMed ID: 15628819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo imaging of beta cells with radiotracers: state of the art, prospects and recommendations for development and use.
    Eriksson O; Laughlin M; Brom M; Nuutila P; Roden M; Hwa A; Bonadonna R; Gotthardt M
    Diabetologia; 2016 Jul; 59(7):1340-1349. PubMed ID: 27094935
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-cell function and mass in type 2 diabetes.
    Larsen MO
    Dan Med Bull; 2009 Aug; 56(3):153-64. PubMed ID: 19728971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SPECT-OPT multimodal imaging enables accurate evaluation of radiotracers for β-cell mass assessments.
    Eter WA; Parween S; Joosten L; Frielink C; Eriksson M; Brom M; Ahlgren U; Gotthardt M
    Sci Rep; 2016 Apr; 6():24576. PubMed ID: 27080529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Carlbom L; Espes D; Lubberink M; Martinell M; Johansson L; Ahlström H; Carlsson PO; Korsgren O; Eriksson O
    Diabetes; 2017 May; 66(5):1286-1292. PubMed ID: 28246291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monitoring of beta cell replacement outcomes.
    Chang CA; Haque WZ; Yoshimatsu G; Balajii PS; Lawrence MC; Naziruddin B
    Panminerva Med; 2016 Mar; 58(1):59-71. PubMed ID: 26763742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positron emission tomography study on pancreatic somatostatin receptors in normal and diabetic rats with 68Ga-DOTA-octreotide: a potential PET tracer for beta cell mass measurement.
    Sako T; Hasegawa K; Nishimura M; Kanayama Y; Wada Y; Hayashinaka E; Cui Y; Kataoka Y; Senda M; Watanabe Y
    Biochem Biophys Res Commun; 2013 Dec; 442(1-2):79-84. PubMed ID: 24220338
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.